Cargando…

Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas

BACKGROUND: As a human tumor disease, head and neck squamous cell carcinoma (HNSCC) is associated with a high mortality rate worldwide. Nicotinic acetylcholine receptors (nAChRs) are transmembrane receptor proteins and exert their biological effects following activation by nicotine. We aimed to cons...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Yujie, Huang, Qiang, Ji, Mengyou, Hsueh, Chi-Yao, Zhou, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594873/
https://www.ncbi.nlm.nih.gov/pubmed/36284268
http://dx.doi.org/10.1186/s12885-022-10161-x
_version_ 1784815528763719680
author Shen, Yujie
Huang, Qiang
Ji, Mengyou
Hsueh, Chi-Yao
Zhou, Liang
author_facet Shen, Yujie
Huang, Qiang
Ji, Mengyou
Hsueh, Chi-Yao
Zhou, Liang
author_sort Shen, Yujie
collection PubMed
description BACKGROUND: As a human tumor disease, head and neck squamous cell carcinoma (HNSCC) is associated with a high mortality rate worldwide. Nicotinic acetylcholine receptors (nAChRs) are transmembrane receptor proteins and exert their biological effects following activation by nicotine. We aimed to construct a prognostic signature based on the expression of nAChRs among smokers with HNSCC. METHODS: The transcriptome profile of nAChRs was obtained from The Cancer Genome Atlas (TCGA). Following the integration of survival information, univariate Cox regression and least absolute shrinkage and selection operator (LASSO) analyses were performed to screen the prognosis-related nAChRs and construct a prognostic signature. Kaplan–Meier (KM), receiver operating characteristic (ROC), principal component analysis (PCA), and independent prognostic analysis were utilized to verify the predictive power of the nAChR-associated prognostic signature. The expression of α5 nAChR in clinical samples was verified by quantitative reverse transcriptase PCR. RESULTS: Subunits α2, α5, α9, and β4 were related to the prognosis. The prognostic signature comprised the expression of subunits α5, α9, and β4. The nAChR-associated signature showed high sensitivity and specificity for prognostic prediction and was an independent factor for overall survival. Based on the clinical variables and expression of nAChRs, a nomogram was constructed for predicting the outcomes of HNSCC patients who were smokers in the clinical settings. In clinical specimens, α5 nAChR showed high expression in HNSCC tissues, especially among smokers. CONCLUSIONS: The nAChR-associated signature constructed in this study may provide a better system for the classification of HNSCC patients and facilitate personalized treatment according to their smoking habits. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10161-x.
format Online
Article
Text
id pubmed-9594873
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95948732022-10-26 Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas Shen, Yujie Huang, Qiang Ji, Mengyou Hsueh, Chi-Yao Zhou, Liang BMC Cancer Research BACKGROUND: As a human tumor disease, head and neck squamous cell carcinoma (HNSCC) is associated with a high mortality rate worldwide. Nicotinic acetylcholine receptors (nAChRs) are transmembrane receptor proteins and exert their biological effects following activation by nicotine. We aimed to construct a prognostic signature based on the expression of nAChRs among smokers with HNSCC. METHODS: The transcriptome profile of nAChRs was obtained from The Cancer Genome Atlas (TCGA). Following the integration of survival information, univariate Cox regression and least absolute shrinkage and selection operator (LASSO) analyses were performed to screen the prognosis-related nAChRs and construct a prognostic signature. Kaplan–Meier (KM), receiver operating characteristic (ROC), principal component analysis (PCA), and independent prognostic analysis were utilized to verify the predictive power of the nAChR-associated prognostic signature. The expression of α5 nAChR in clinical samples was verified by quantitative reverse transcriptase PCR. RESULTS: Subunits α2, α5, α9, and β4 were related to the prognosis. The prognostic signature comprised the expression of subunits α5, α9, and β4. The nAChR-associated signature showed high sensitivity and specificity for prognostic prediction and was an independent factor for overall survival. Based on the clinical variables and expression of nAChRs, a nomogram was constructed for predicting the outcomes of HNSCC patients who were smokers in the clinical settings. In clinical specimens, α5 nAChR showed high expression in HNSCC tissues, especially among smokers. CONCLUSIONS: The nAChR-associated signature constructed in this study may provide a better system for the classification of HNSCC patients and facilitate personalized treatment according to their smoking habits. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12885-022-10161-x. BioMed Central 2022-10-25 /pmc/articles/PMC9594873/ /pubmed/36284268 http://dx.doi.org/10.1186/s12885-022-10161-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Shen, Yujie
Huang, Qiang
Ji, Mengyou
Hsueh, Chi-Yao
Zhou, Liang
Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas
title Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas
title_full Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas
title_fullStr Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas
title_full_unstemmed Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas
title_short Smoking-mediated nicotinic acetylcholine receptors (nAChRs) for predicting outcomes for head and neck squamous cell carcinomas
title_sort smoking-mediated nicotinic acetylcholine receptors (nachrs) for predicting outcomes for head and neck squamous cell carcinomas
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594873/
https://www.ncbi.nlm.nih.gov/pubmed/36284268
http://dx.doi.org/10.1186/s12885-022-10161-x
work_keys_str_mv AT shenyujie smokingmediatednicotinicacetylcholinereceptorsnachrsforpredictingoutcomesforheadandnecksquamouscellcarcinomas
AT huangqiang smokingmediatednicotinicacetylcholinereceptorsnachrsforpredictingoutcomesforheadandnecksquamouscellcarcinomas
AT jimengyou smokingmediatednicotinicacetylcholinereceptorsnachrsforpredictingoutcomesforheadandnecksquamouscellcarcinomas
AT hsuehchiyao smokingmediatednicotinicacetylcholinereceptorsnachrsforpredictingoutcomesforheadandnecksquamouscellcarcinomas
AT zhouliang smokingmediatednicotinicacetylcholinereceptorsnachrsforpredictingoutcomesforheadandnecksquamouscellcarcinomas